Neurologist Dr. Kenichiro Ono discusses deep brain stimulation and treating epilepsy. Neurologist Dr. Kenichiro Ono talks about collaborating with researchers at Virginia Commonwealth University that ...

About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies. Yet they too may eventually see improvement, if not ...

Please provide your email address to receive an email when new articles are posted on . Transdermal CBD was well tolerated and safe among those with drug-resistant focal epilepsy, although no efficacy ...

Please provide your email address to receive an email when new articles are posted on . XEN1101 is a novel small-molecule selective Kv7.2/Kv7.3 potassium channel opener. A 25 mg dose of XEN1101 ...

Investment from XGEN Venture, British Business Bank, and a global biopharmaceutical company will support first-in-human Phase 1/2a clinical trials for lead candidate EPY201 targeting focal refractory ...

Optimal sleep appears to offer some protection against risk for dementia, with improved effects among people with focal epilepsy.

Suicidality at the time of a focal epilepsy diagnosis was associated with a higher risk for future treatment resistance to antiseizure medications (ASMs), independent of concurrent mood or anxiety ...

Research has shown early diagnosis and treatment of epilepsy disorders can improve outcomes. The question of when to ...

Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time pointsX-TOLE2 data featured in Late-breaking Science session show 53.2% reduction in ...

For people with epilepsy, getting poor sleep was associated with a higher risk of dementia compared to people without ...